Last reviewed · How we verify

NCT04318288

Comparison of Anthropometric Parameters and Cardiometabolic Risk Factors Among Subjects With Overweight and Obesity

Completed Last updated 24 March 2020
What this trial tests

trial testing Observational in Obesity in 1,214 participants. Completed in 20 December 2019.

Timeline
7 January 2019
Primary endpoint
30 November 2019
20 December 2019

Quick facts

Lead sponsorAzienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis
StatusCompleted
Study typeOBSERVATIONAL
Enrollment1,214
Start date7 January 2019
Primary completion30 November 2019
Estimated completion20 December 2019
Sites1 location across Italy

Drugs / interventions tested

Conditions studied

Sponsor

Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis

Who can join

Eligibility, any sex, with Obesity. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The study was aimed at comparing four different anthropometric parameters to cardiometabolic risk factors in overweight and obese subjects (Body Mass Index (BMI)≥25)

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Cross-sectional relationship among different anthropometric parameters and cardio-metabolic risk factors in a cohort of patients with overweight or obesity.
    Lampignano L, Zupo R, Donghia R, Guerra V, et al · · 2020 · cited 14× · PMID 33152746 · DOI 10.1371/journal.pone.0241841

Verify or expand the search:

Other trials of Observational

Trials testing the same drug.

Other recruiting trials for Obesity

Currently open trials in the same condition.

Other Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04318288.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing